Prnewswire Occlutech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prnewswire occlutech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prnewswire Occlutech Today - Breaking & Trending Today

Occlutech announces Completion of Patient Enrolment in Pilot Study of Atrial Flow Regulator (AFR) in Patients with Heart Failure

Occlutech announces Completion of Patient Enrolment in Pilot Study of Atrial Flow Regulator (AFR) in Patients with Heart Failure
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Sabine Bois , Prnewswire Occlutech , Occlutech International , Occlutech Group , Atrial Flow Regulator , ஒன்றுபட்டது மாநிலங்களில் , ஸெபீந் போயிஸ் , ஏட்ரியல் ஓட்டம் சீராக்கி ,

Occlutech announces Completion of Patient Enrolment in Pilot Study of Atrial Flow Regulator (AFR) in Patients with Heart Failure

Occlutech announces Completion of Patient Enrolment in Pilot Study of Atrial Flow Regulator (AFR) in Patients with Heart Failure
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Kostenloser Wertpapierhandel , Prnewswire Occlutech , Sabine Bois , Occlutech Group , Atrial Flow Regulator , ஒன்றுபட்டது மாநிலங்களில் , ஸெபீந் போயிஸ் , ஏட்ரியல் ஓட்டம் சீராக்கி ,

Occlutech announces Completion of Patient Enrolment in Pilot Study of Atrial Flow Regulator (AFR) in Patients with Heart Failure

Occlutech announces Completion of Patient Enrolment in Pilot Study of Atrial Flow Regulator (AFR) in Patients with Heart Failure
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Sabine Bois , Prnewswire Occlutech , Occlutech International , Occlutech Group , Atrial Flow Regulator , ஒன்றுபட்டது மாநிலங்களில் , ஸெபீந் போயிஸ் , ஏட்ரியல் ஓட்டம் சீராக்கி ,

Occlutech's Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation for Heart Failure (HF)

Share this article
Share this article
SCHAFFHAUSEN, Switzerland, Jan. 19, 2021 /PRNewswire/ Occlutech, a privately-held company, announced today that the U.S Food and Drug Administration (FDA) has granted the Company a Breakthrough Device designation for its first-in-class, implantable Atrial Flow Regulator (AFR) for heart failure (HF) patients with preserved (HFpEF) or reduced (HFrEF) ejection fraction.
Heart failure (HF) is a serious condition characterized by the heart s inability to pump an adequate blood supply to the body. Worldwide, HF affects over 30 million people, and the lifetime risk of HF increases with age, with over 50% of hospitalizations of persons aged 65 or older attributable to HF. Heart Failure Symptoms include fatigue, palpitations, and exertional dyspnea. HF may result from disorders of the pericardium, myocardium, endocardium, heart valves, great vessels, or specific metabolic abnormalities. These disorders affect the heart s structure or fu ....

United States , Sabine Bois , Prnewswire Occlutech , Occlutech International , Companya Breakthrough Device , Drug Administration , Occlutech Group , Breakthrough Device , Atrial Flow Regulator , Heart Failure Symptoms , Heart Failure , Preserved Ejection Fraction , Reduced Ejection Fraction , Device Designations , ஒன்றுபட்டது மாநிலங்களில் , ஸெபீந் போயிஸ் , திருப்புமுனை சாதனம் , ஏட்ரியல் ஓட்டம் சீராக்கி , இதயம் தோல்வி அறிகுறிகள் , இதயம் தோல்வி , ப்ரிஸர்வ்ட் வெளியேற்றம் பின்னம் , குறைக்கப்பட்டது வெளியேற்றம் பின்னம் ,

Occlutech's Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation

Press release content from PR Newswire. The AP news staff was not involved in its creation.
Occlutech’s Atrial Flow Regulator (AFR) Receives U.S. FDA Breakthrough Device Designation
December 18, 2020 GMT
SCHAFFHAUSEN, Switzerland, Dec. 18, 2020 /PRNewswire/ Occlutech, a privately-held company, announced today that the US Food and Drug Administration (FDA) has granted the company a Breakthrough Device designation for its first-in-class, implantable Atrial Flow Regulator (AFR) for Pulmonary Arterial Hypertension (PAH).
PAH affects hundreds of thousands in the U.S. and globally and is resulting from changes in cells that causes damages of the lung arteries. Consequentially, the heart is forced to work harder to supply enough oxygen. The patient experiences symptoms such as shortness of breath, dizziness and fatigue. The severity of these symptoms usually correlates with progression of the disease and significantly reduced quality of life. Over time, the right vent ....

United States , Sabine Bois , Prnewswire Occlutech , Occlutech International , Drug Administration , Occlutech Group , Breakthrough Device , Atrial Flow Regulator , Pulmonary Arterial Hypertension , Device Designations , ஒன்றுபட்டது மாநிலங்களில் , ஸெபீந் போயிஸ் , திருப்புமுனை சாதனம் , ஏட்ரியல் ஓட்டம் சீராக்கி , நுரையீரல் தமனி உயர் இரத்த அழுத்தம் ,